Pediatrics Doctors in Livonia, LA Accepting Medicare
1 Pediatrics doctors found. Showing 1 - 1
 Federica Cherill Williams, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8387 Newfield Dr, Livonia, LA 70755 Phone: 225-412-0202 |
News Archive
Study shows 82 percent of U.S. homes have mouse allergens
NIEHS researchers analyzed dust samples, asked questions, and examined homes in the first National Survey of Lead and Allergens in Housing, a survey of 831 homes. Allergen levels were studied and related to demographic factors and household characteristics.
Study highlights need for culturally relevant programs to educate Black communities on hepatitis B
Hepatitis B disproportionately impacts U.S. Blacks, including African American and Haitian Blacks. Both communities suffer from widespread misinformation and access to care issues that might avert disease detection and prevention, according to a study published in Cancer Causes & Control by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.
Liquent and eSA enter strategic partnership
Liquent, Inc. today announced it has entered into a strategic partnership with eSA, Inc., a leading solutions provider for regulatory information management and regulatory services within Asia. Through an exclusive agreement, eSA will now have the commercial and technical support responsibilities for Liquent's strategic offerings, Liquent InSight and Liquent SmartDesk.
Bulldogs' screw tails linked to rare inherited syndrome in humans
With their small size, stubby faces and wide-set eyes, bulldogs, French bulldogs and Boston terriers are among the most popular of domestic dog breeds. Now researchers at the University of California, Davis, School of Veterinary Medicine have found the genetic basis for these dogs' appearance, and linked it to a rare inherited syndrome in humans.
Alchemia's HyACT tumour targeting technology enhances killing of cancer stem cells
Alchemia's subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research (AACR) 101st Annual Meeting in Washington, DC. The data demonstrates the ability of the Company's HyACT tumour targeting technology to dramatically enhance the killing of cancer stem cells. These cells are highly resistant to treatment with chemotherapeutic drugs and are believed to be responsible for treatment failure and disease recurrence.
› Verified 2 days ago